Literature DB >> 22555174

Ciliated adenocarcinomas of the lung: a tumor of non-terminal respiratory unit origin.

Won Young Park1, Mi Hyun Kim, Dong Hoon Shin, Jung Hee Lee, Kyung Un Choi, Jee Yeon Kim, Do Youn Park, Chang Hun Lee, Mee Young Sol.   

Abstract

Whereas most carcinomas occur through a sequential step, atypical adenomatous hyperplasia and bronchioloalveolar carcinoma pathway is known for pulmonary adenocarcinoma. This type is known as terminal respiratory unit adenocarcinoma. Based on our observation of transitions from normal ciliated columnar cells to adenocarcinoma via dysplastic mucous columnar cells, we reviewed our archive of pulmonary adenocarcinoma. Terminal respiratory unit type adenocarcinoma was defined as adenocarcinoma with type II pneumocyte, Clara cell, or bronchiolar cell morphology according to previous reports. Among 157 cases, 121 cases have been identified as terminal respiratory unit type adenocarcinoma and 36 cases as non-terminal respiratory unit type adenocarcinoma. Among non-terminal respiratory unit type adenocarcinoma, 24 cases revealed mucous columnar cell changes that were continuous with bronchial ciliated columnar cells. The mucous columnar cells became dysplastic showing loss of cilia, disorientation, and enlarged nuclei. Adenocarcinoma arose from these dysplastic mucous columnar cells and, characteristically, this type of adenocarcinoma showed acute inflammation, and honeycombing changes in the background. TTF1 immunostaining was consistently negative. In a case study with 14 males and 10 females, including 12 smokers or ex-smokers, EGFR and KRAS mutations were detected in 3 and 6 patients, respectively. We think that this kind of adenocarcinoma arising through mucous columnar cell change belongs to non-terminal respiratory unit type adenocarcinoma, and mucous columnar cell change is a precursor lesion of pulmonary adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555174     DOI: 10.1038/modpathol.2012.76

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  CRISPR-Cas9 knockin mice for genome editing and cancer modeling.

Authors:  Randall J Platt; Sidi Chen; Yang Zhou; Michael J Yim; Lukasz Swiech; Hannah R Kempton; James E Dahlman; Oren Parnas; Thomas M Eisenhaure; Marko Jovanovic; Daniel B Graham; Siddharth Jhunjhunwala; Matthias Heidenreich; Ramnik J Xavier; Robert Langer; Daniel G Anderson; Nir Hacohen; Aviv Regev; Guoping Feng; Phillip A Sharp; Feng Zhang
Journal:  Cell       Date:  2014-09-25       Impact factor: 41.582

Review 2.  Cilia dysfunction in lung disease.

Authors:  Ann E Tilley; Matthew S Walters; Renat Shaykhiev; Ronald G Crystal
Journal:  Annu Rev Physiol       Date:  2014-10-29       Impact factor: 19.318

3.  Ciliated HPV-related Carcinoma: A Well-differentiated Form of Head and Neck Carcinoma That Can Be Mistaken for a Benign Cyst.

Authors:  Justin A Bishop; William H Westra
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

4.  KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.

Authors:  Yusuke Takanashi; Shogo Tajima; Takamitsu Hayakawa; Hiroshi Neyatani; Kazuhito Funai
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Pulmonary papillary adenocarcinoma with Aspergillus versicolor infection in a dog.

Authors:  Rathiymaler Maniam; Gayathri Thevi Selvarajah; Mazlina Mazlan; Leslie Thian Lung Than
Journal:  Med Mycol Case Rep       Date:  2017-12-01

6.  A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening.

Authors:  Jrhau Lung; Ming-Szu Hung; Yu-Ching Lin; Yuan Yuan Jiang; Yu-Hung Fang; Ming-Shian Lu; Ching-Chuan Hsieh; Chia-Siu Wang; Feng-Che Kuan; Chang-Hsien Lu; Ping-Tsung Chen; Chieh-Mo Lin; Yen-Li Chou; Chin-Kuo Lin; Tsung-Ming Yang; Fen Fen Chen; Paul Yann Lin; Meng-Jer Hsieh; Ying Huang Tsai
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

7.  Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.

Authors:  Sung-Jun Ko; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jin-Haeng Chung; Tae Jung Kim; Kyung Won Lee; Kwhanmien Kim; Sanghoon Jheon; Hyojin Kim; Jae Ho Lee; Choon-Taek Lee
Journal:  BMC Cancer       Date:  2014-05-03       Impact factor: 4.430

Review 8.  The cilia-regulated proteasome and its role in the development of ciliopathies and cancer.

Authors:  Christoph Gerhardt; Tristan Leu; Johanna Maria Lier; Ulrich Rüther
Journal:  Cilia       Date:  2016-06-10

9.  Discriminating between Terminal- and Non-Terminal Respiratory Unit-Type Lung Adenocarcinoma Based on MicroRNA Profiles.

Authors:  Mi-Hyun Kim; Jeong Su Cho; Yeongdae Kim; Chang Hun Lee; Min Ki Lee; Dong Hoon Shin
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

10.  Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma.

Authors:  Dae Hyeon Kim; So Young Bae; Kwon Joong Na; Samina Park; In Kyu Park; Chang Hyun Kang; Young Tae Kim
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.